UROWebinar: PARP inhibitors in prostate cancer management
Автор: European School of Urology
Загружено: 2025-03-12
Просмотров: 687
Описание:
PARP inhibitors in prostate cancer management
Organised by the European School of Urology and the EAU Section of Oncological Urology, this recording will focus on the role of poly-ADP ribose polymerase (PARP) inhibitors in prostate cancer (PCa) management.
PARP inhibitors have emerged as a game-changer in PCa treatment, offering new therapeutic options for patients with advanced disease. How do they fit into current clinical practice? What are the latest developments, patient selection criteria, and practical considerations for their use?
Join our discussion as we explore the role of PARP inhibitors, review key clinical data, and discuss their integration into PCa management.
Speakers:
Assoc. Prof. J. Gómez Rivas (ES)
Assoc. Prof. J. Aning (GB)
Drs. C. Mercinelli (IT)
Prof. Dr. A.S. Merseburger (DE)
This recording is brought to you in collaboration with the EAU Section of Oncological Urology.
Acknowledgment
This activity is supported by an educational grant from our industry partner - MSD, with no involvement in the programme or speaker selection:
https://www.msd.com/.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
